ALSTODT LANCE - Insider Non-Derivative Transactions at BioRestorative Therapies, Inc. (BRTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 18, 2024, ALSTODT LANCE's relationship to BioRestorative Therapies, Inc. (BRTX) is Director,Officer (President, CEO, COB), and currently has 171,872 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BRTX insiders.

Data Source: SEC.
ALSTODT LANCE - Insider Non-Derivative Transactions of BRTX Common Stock
ALSTODT LANCE - Insider Non-Derivative Transactions at BRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 19, 2024 F -- (Common Stock) 17633 1.39 171872
Sep 16, 2023 P -- (Common Stock) 2200 1.7 189505
Sep 14, 2023 P -- (Common Stock) 800 1.53 188105
Sep 7, 2023 P -- (Common Stock) 2887 1.96 187305
Jul 26, 2023 P -- (Common Stock) 4200 2.44 184418
Mar 21, 2023 F -- (Common Stock) 6729 2.92 180218
Feb 19, 2023 F -- (Common Stock) 374 2.99 186947
Feb 2, 2023 P -- (Common Stock) 400 3.1 187321
Jan 28, 2023 P -- (Common Stock) 200 3.01 186921
Jan 21, 2023 P -- (Common Stock) 100 3.1 186621
Jan 21, 2023 P -- (Common Stock) 100 3.17 186721
Jan 19, 2023 P -- (Common Stock) 200 3.13 186321
Jan 19, 2023 P -- (Common Stock) 100 3.1 186421
Jan 19, 2023 P -- (Common Stock) 100 3.09 186521
Jan 10, 2023 P -- (Common Stock) 100 3.08 186121